Want to join the conversation?
Global biotech company $BIIB reported a surge of 11% in its 3Q15 revenue to $2.8Bil. Net income and diluted EPS also surged significantly by 13% and 15% respectively. Net income was at $966MM while diluted EPS was at $4.15. FX, offset by hedging, weakened total revenues by approx. $63MM compared to 3Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?